Exhibit 23.4
Consent of Independent Registered Public Accounting Firm
Addex Therapeutics Ltd
Geneva, Switzerland
We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Post-Effective Amendment No. 1 to the Registration Statement on Form F-1 (File No. 333-262050) of our report dated March 10, 2022, relating to the consolidated financial statements of Addex Therapeutics Ltd appearing in the Company’s Annual Report on Form 20-F for the year ended December 31, 2021.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
BDO AG | |
Christoph Tschumi | Nigel Le Masurier |
Zurich, March 31, 2022